apjohndim.com

Menu

New

New

Η καινοτομία σε πρώτο πλάνο στο περίπτερο του ΙΕΧΜΗ στο PatrasIQ! 🔬

/

Η καινοτομία σε πρώτο πλάνο στο περίπτερο του ΙΕΧΜΗ στο PatrasIQ! 🔬 Η εκθεσιακή μας παρουσία στην 9η Έκθεση Καινοτομίας & Μεταφοράς Τεχνογνωσίας Patras IQ κλέβει τις εντυπώσεις! Σας περιμένουμε στα περίπτερά μας (27 Φεβρουαρίου – 1 Μαρτίου) για να δείτε από κοντά τις τεχνολογίες του μέλλοντος και πώς η έρευνα του Institute of Chemical Engineering Sciences (FORTH/ICE-HT) μετατρέπεται σε λύσεις με παγκόσμιο αντίκτυπο. 🔬 Εργαστηριακά Εκθέματα Αιχμής: 🌏 Περιβάλλον: Ο Αντιδραστήρας Ψυχρού Πλάσματος για καθαρισμό νερού (Εργ. Christos Aggelopoulos). 🏭 Ενέργεια: Καινοτόμες μπαταρίες και υπερπυκνωτές με ηλεκτρόδια γραφενίου (Εργ. Σπ. Γιαννόπουλου). 🖼️ Υλικά: Η χρήση του γραφενίου για την προστασία έργων τέχνης (Εργ. Costas Galiotis). 💼 Επιχειρηματικότητα & Spin-offs: Γνωρίστε τις λύσεις των emAIRging (ποιότητα αέρα) και Hellenic-CAM, που αποδεικνύουν έμπρακτα πώς η έρευνα γίνεται ανταγωνιστικό προϊόν. 🤝 Στρατηγικοί Συνεργάτες: Είμαστε ιδιαίτερα χαρούμενοι που έχουμε δίπλα μας τους υποστηρικτικούς πυλώνες του ΙΤΕ, το Δίκτυο ΠΡΑΞΗ (PRAXI Network) και το Επιστημονικό Τεχνολογικό Πάρκο Κρήτης (Science & Technology Park of Crete (STEP-C), ενισχύοντας καθημερινά τη γέφυρα μεταξύ έρευνας και παραγωγής. Ελάτε να συζητήσουμε για το αύριο της τεχνολογίας και να οραματιστούμε μαζί τις επόμενες μεγάλες καινοτομίες! 📍 Συνεδριακό & Πολιτιστικό Κέντρο Πανεπιστημίου Πατρών, α΄ όροφος   https://www.linkedin.com/posts/institute-of-chemical-engineering-sciences-forth_forth-iceht-patrasiq-activity-7433468907245576192-vTmS?utm_source=share&utm_medium=member_desktop&rcm=ACoAACOuBnUBHGaEEvH4ZIGbKKGODojq0eVurG4

New

Η EmAIRging στο 9ο Patras IQ 2026

/

Η EmAIRging συμμετέχει στην 9η Έκθεση Καινοτομίας & Μεταφοράς Τεχνογνωσίας Patras IQ, από τις 27 Φεβρουαρίου έως την 1η Μαρτίου, στο Συνεδριακό Κέντρο του Πανεπιστημίου Πατρών. Σας περιμένουμε στο περίπτερο του ΙΤΕ/ΙΕΧΜΗ για να συζητήσουμε από κοντά έξυπνες λύσεις για την παρακολούθηση της ποιότητας του αέρα και τη συμβολή της τεχνολογίας σε πιο υγιείς και βιώσιμους χώρους. https://www.linkedin.com/posts/activity-7432035757441085441-_xF0?utm_source=share&utm_medium=member_desktop&rcm=ACoAACOuBnUBHGaEEvH4ZIGbKKGODojq0eVurG4  

New

AIRIN receives Gold and Platinum distinctions at the AI & Data Awards 2026

/

I’m happy to share that our project AIRIN: Medical Decision Support System for Explainable AI-driven Diagnosis of Ophthalmic Diseases was recognised at the AI & Data Awards 2026 powered by UBITECH, during the awards ceremony held in Athens on 27 January 2026. AIRIN received both a Gold and a Platinum distinction in Best Machine Learning Solution—a meaningful acknowledgement that sustained, careful work on clinically-relevant and explainable AI does not go unnoticed. More importantly, it reflects positive feedback from the broader community on the practical value of the innovative approaches we are proposing. Special thanks go to the two scientific leads who carry the largest share of the ideation and direction behind AIRIN: Prof. Elpiniki Papageorgiou and Dr. Eirini Maliagkani. Their insight, standards, and consistency are central to what this project has become. AIRIN is developed through the collaboration of ACTA Lab (University of Thessaly) and the 1st University Ophthalmology Clinic, National and Kapodistrian University of Athens (NKUA).

New

Recognized in the World’s Top 2% Scientists (2023–2025)

/

I’m honored to be listed for three consecutive years (2023, 2024, 2025) in Stanford/Elsevier’s “World’s Top 2% Scientists.” The trajectory across recent years shows steady progress (subfield ranks: 8,330/356,955 in 2023, 7,462/399,064 in 2024, 6,364/458,615 in 2025). Data are verified from the Elsevier/Stanford dataset. Source: Scopus Find out about my full profile at Top SCINET

New

Editorial Role at the Journal of Medical Systems

/

I’m honored to share that I have been appointed as an Associate Editor for the Journal of Medical Systems! This opportunity marks a meaningful milestone in my academic and professional journey. I’m excited to contribute to the peer review and editorial process, support high-quality research, and collaborate with a global community of scholars advancing the intersection of healthcare and technology. The Journal of Medical Systems: The Home of Clinical Informatics Research is a top-tier informatics journal that focuses on the latest methods in health information systems and informatics techniques. Journal publishes informative original articles, reviews, and studies across the entire scale of medical systems, from large hospital programs to novel small-scale medical services. Education is an integral part of this amalgamation of sciences, and selected articles are published in this area.  

New

Clinical validation of the EMERALD’s MDSS t the University Hospital of Patras

/

On April 1st, 2025, the developed Medical Decision Support System (MDSS) was clinically validated at the University Hospital of Patras, marking a significant milestone in the project. Under the scientific coordination of Professor Elpiniki Papageorgiou (Principal Investigator), the validation was supported by members of the EMERALD team, including Associate Professor Nikolaos Papandrianos, Professor of Nuclear Medicine Dimitrios Apostolopoulos, Postdoctoral Researcher Dr. Ioannis Apostolopoulos, and Associate Professor Theodosis Theodosiou. The evaluation involved the use of anonymized clinical records referring to Coronary Artery Disease and Non-small Cell Lung Cancer for evaluating the functionalities and diagnostic performance of the MDSS. Real diagnostic workflows were simulated, closely mirroring the conditions faced by healthcare professionals in practice. Clinicians assessed the system’s performance based on diagnostic accuracy, interpretability, and usability. The MDSS’s explainability tools were especially valued for providing transparent, understandable justifications for each prediction. Additional features, such as the natural language generation module, further enhanced the system’s usability and integration into clinical routines. This collaborative effort between AI researchers and healthcare professionals ensured that the system’s capabilities were aligned with practical clinical expectations and needs. The pilot deployment validated the MDSS as a clinically reliable and ethically grounded decision-support tool. It demonstrated high predictive precision and received strong endorsement from medical experts, who emphasized its potential to streamline diagnostic workflows and reduce diagnostic uncertainty. The clinical team’s feedback provided valuable recommendations for future refinements, aimed at broadening the system’s applicability and facilitating deeper integration into diverse healthcare environments. These findings reinforce EMERALD’s mission to deliver impactful, interpretable, and clinically relevant AI solutions for medical decision support.

New

Silver award in AI & Data Awards 2025

/

The Artificial Intelligence, Computational Systems, and Technological Applications Laboratory (ACTA Lab) of the University of Thessaly, directed by Professor of Artificial Intelligence and Expert Systems, Dr. Elpiniki Papageorgiou and Principal Investigator of project EMERALD, has received a prestigious distinction in the field of Artificial Intelligence and Data. Prof. Papageorgiou and her research team won the Silver Award at the AI & Data Awards 2025 in the category AI & Data Solutions – Best Machine Learning Solution. The AI & Data Awards 2025 ceremony took place on Thursday, February 27, at Technopolis City of Athens, under the auspices of the Ministry of Digital Governance, with the support of the National Documentation Centre (EKT) and powered by UBITECH. Organized for the first time by Boussias Events, the event was dedicated to Innovation and Excellence, bringing together industry leaders, innovative professionals, and pioneers in Artificial Intelligence and Data Science. The award-winning solution, EMERALD, is a cutting-edge artificial intelligence application based on advanced machine learning algorithms, fuzzy cognitive analytics and explainable AI. Its goal is to enhance diagnostic capabilities and decision-making in the healthcare sector, and particular in Nuclear Medical diagnosis, making a significant contribution to the scientific, clinical, social, and commercial utilization of technology. A special honor for ACTA Lab, as it was the only University Laboratory to be awarded among companies and professionals in the Greek market, in a highly competitive event with an exceptionally high level of participation. This distinction highlights the importance of academic research in shaping innovative solutions with practical applications in the business world, addressing  complex challenges in critical fields such as healthcare and data analysis. The Director of ACTA Lab, who founded the first Artificial Intelligence laboratory at the School of Technology at University of Thessaly, nearly two years ago, stated: “I am particularly delighted with this significant distinction, which showcases the potential of academic research to provide substantial solutions for society and the market. This award is the culmination of our team’s collective effort and gives us the momentum to continue researching, creating, and innovating.” About ACTA Lab: The Artificial Intelligence, Computational Systems, and Technological Applications Laboratory (ACTA Lab) at the University of Thessaly specializes in research and development of advanced technological solutions, with a focus on artificial intelligence, machine learning, and data analysis.Through an interdisciplinary approach, ACTA Lab aims to bridge the gap between academic research and industry, delivering innovative applications in key sectors such as healthcare, industry, education, energy, and environment. For more information about EMERALD project, visit: https://emerald.uth.gr For more information about ACTA Lab, visit: https://acta.energy.uth.gr Contact: Prof. Elpiniki Papageorgiou +30 2410 684567 elpinikipapageorgiou@uth.grAwa

Scroll to Top
Name
My interests
I will use any given material for educational non-profit purposes